Blog

It’s no secret that the top health concern on most Americans’ minds today is COVID-19 – a unprecedented disrupter like we’ve never seen before. However, as the pandemic rages on, many are trying to move forward and keep things in motion and retaining as much sense of normalcy as possible during these challenging times. There...

Read more +

Cancer remains a leading cause of death among Americans with nearly two million newly diagnosed patients in 2018. As this trend continues, various...

Read more +

Recently, there have been published reports stating that a large proportion of studies published in high-impact scientific journals could not be...

Read more +

A sound preclinical plan coupled with expert oncology guidance can help identify biomarkers that can assist with patient selection—or help...

Read more +

Too often, new drugs fail during development due to poor study design and inadequate knowledge about the performance of a new drug. A large part of...

Read more +

If you’re exploring nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH) or cancer-associated liver fibrosis, you may want...

Read more +

Ketogenic diets—which involve higher saturated fat, moderate protein and low carbohydrate consumption—have been successfully used to manage human...

Read more +

Don’t skip important steps in preclinical research: drug metabolism and pharmacokinetic analysis (DMPK). DMPK Quick Tips More and more, researchers...

Read more +

Often, new drug makers come across a potential anticancer agent—and as they consider evaluating that agent further, they tend to confront this...

Read more +

Sometimes, the U.S. FDA is criticized as incapable in comparison with its European counterpart, the EMEA. Particularly this criticism is commonly...

Read more +

Oncology drug development is important for numerous drug developers, funding bodies and academic researchers. This has caused a wealth of new...

Read more +

View More